Heritage Cannabis Holdings Corp. subsidiary Voyage receives Industrial Hemp License from Health Canada

- April 23rd, 2020

Heritage Cannabis’ subsidiary Voyage Cannabis has been granted an industrial hemp license by Health Canada, effective April 17, 2020 to April 17, 2023.

Heritage Cannabis Holdings Corp. (CSE:CANN) (CNSX:CANN.CN) (OTC:HERTF) (“Heritage” or the “Company”), a leading Canadian cannabis company is pleased to announce that its subsidiary Voyage Cannabis Corp. (“Voyage”) has been granted an industrial hemp license by Health Canada, effective April 17, 2020 to April 17, 2023. Similar to the license recently granted to Heritage’s other subsidiary Cannacure Corp., the industrial hemp license will allow Voyage to bulk store, as well as buy and sell industrial hemp, flowering heads, leaves or branches to other license holders, and to import and export grain.

Heritage has been producing full spectrum CBD from high quality hemp biomass as part of the Company’s medical and recreational product initiatives. It is expected that these products will be available to the public within the next few months.

“Receiving our second industrial hemp license this month benefits our operations and allows us to participate in the rapidly growing hemp and CBD markets in a more meaningful way,” stated Clint Sharples, CEO of Heritage. “We are now able to purchase and store greater quantities of hemp on both sides of the country and can further support hemp farmers by augmenting their storage capacity in a controlled environment.”

About Heritage Cannabis Holdings Corp.

Heritage Cannabis currently has two Health Canada approved licenced producers through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp., both regulated under the Cannabis Act Regulations. Working under these two licences, Heritage has two additional subsidiaries, Purefarma Solutions, which provides extraction services, and a Medical Services Division which is focused on cannabis based medical solutions. Heritage as the parent company, is focused on providing the resources for its subsidiaries to advance their products or services to compete both domestically and internationally.

ON BEHALF OF THE BOARD OF DIRECTORS OF HERITAGE CANNABIS HOLDINGS CORP.

“Clint Sharples”

Clint Sharples

CEO

For more information contact:

Clint Sharples

Tel: 416-705-8529

csharples@heritagecann.com

or

Kelly Castledine

Tel: 647-660-2560

kcastledine@heritagecann.com

The Canadian Stock Exchange does not accept responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors – including the availability of funds, the results of financing efforts, the results of exploration activities — that could cause actual results to differ materially from the Company’s expectations are disclosed in the Company’s documents filed from time to time on SEDAR (see www.sedar.com). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Click here to connect with Heritage Cannabis Holdings Corp. (CSE:CANN) for an Investor Presentation.

Source

 

New FREE Report: Investing in Psychedelics

   
What’s ahead for this exciting new segment? Learn more with our exclusive psychedelics report today. Published July 6, 2020.
 

Get the latest Cannabis Investing stock information

Leave a Reply